Managing benign prostatic hyperplasia.
Garnett
S
S
Bristol Urological Institute, Southmead Hospital, Bristol.
Abrams
P
P
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D018120:Finasteride; D017430:Prostate-Specific Antigen